Effect of Lovastatin on Serum Osteoprotegerin Level in Type 2 Diabetic Nephropathy
BACKGROUND AND OBJECTIVE: Osteoprotegerin (OPG), a glycoprotein is a member of the tumor necrotizing factor alpha receptor super-family. By considering the possible role of OPG in cardiovascular disease (CVD), higher incidence of CVD in patients with type 2 diabetic nephropathy (T2DN), and anti-athe...
Guardado en:
Autores principales: | N Nezami, M Asghari, J Safa, MM Bagheri Asl, B Salari, S Ghorashi |
---|---|
Formato: | article |
Lenguaje: | EN FA |
Publicado: |
Babol University of Medical Sciences
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8ef0821f5b8f426f82f0b87957b91070 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss
por: Anne-Priscille Trouvin, et al.
Publicado: (2010) -
ASSESSMENT OF THE HYDROLYTIC DEGRADATION OF LOVASTATIN BY HPLC
por: ÁLVAREZ-LUEJE,A, et al.
Publicado: (2005) -
Evaluating Risk of Incident Diabetes Between Patients Who Used Lovastatin and Red Yeast Rice Prescriptions (LipoCol Forte): A Retrospective Cohort Study Based on a Real-World Database
por: Chen TL, et al.
Publicado: (2020) -
Effect of Alcoholic Extract of Thymbra Spicata on Blood Lipid Profile in Compared with Lovastatin in Male Rats
por: M Asadi,, et al.
Publicado: (2012) -
Controlled release of lovastatin from poly(lactic-co-glycolic acid) nanoparticles for direct pulp capping in rat teeth
por: Lin HP, et al.
Publicado: (2017)